AMOBEST
AMOBEST
(Amikacin Sulphate Injection I.P. 500 mg / 2 ml)
Composition:
Each 2 ml contains:
Amikacin Sulphate I.P.
Eq. to Amikacin 500 mg
Sodium Citrate I.P. 0.5% w/v
Methylparaben I.P. 0.1% w/v
(As preservatives)
Propylparaben I.P. 0.02% w/v
(As preservative)
Sodium Metabisulphite I.P. 0.05% w/v
Water for Injections I.P. q.s.
Packaging:
100 ml
Product Description
AMOBEST Tablets is a broad-spectrum veterinary antibiotic formulation containing Amoxycillin 250 mg and Clavulanic Acid 125 mg. This synergistic combination offers enhanced antibacterial activity against a wide range of Gram-positive and Gram-negative organisms, including β-lactamase producing resistant strains. Amoxycillin acts by inhibiting bacterial cell wall synthesis, leading to bacterial cell death, while Clavulanic Acid protects Amoxycillin from enzymatic degradation, thereby extending its spectrum of action.
AMOBEST is indicated for the treatment of various bacterial infections in animals, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, gastrointestinal infections, and dental infections. It is also effective in managing post-surgical infections and wound infections. The formulation ensures reliable therapeutic efficacy, faster recovery, and improved infection control in veterinary practice.
Indications:
-
- Treatment of respiratory tract infections (bronchitis, pneumonia)
- Management of urinary tract infections (UTIs)
- Treatment of skin and soft tissue infections (wounds, abscesses, pyoderma)
- Management of gastrointestinal infections
- Treatment of dental infections and oral cavity infections
- Control of post-surgical infections
- Effective in infections caused by β-lactamase–producing bacteria
Therapeutic Segment Positioning:
Antibiotic (Veterinary)
